Darwin Global Management, Ltd. Quant / Systematic

CIK: 0001839209 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $859,474 (100.0% shares, 0.0% debt)

Holdings (9)

CYTK CYTOKINETICS INC 28.6%

Value ($000) $246,074 Shares 4,575,558 Est. Cost $60.36 Unrealized 0.0%

INSM INSMED INC 27.6%

Value ($000) $237,076 Shares 3,541,095 Est. Cost $38.78 Unrealized 0.0%

PCVX VAXCYTE INC 19.1%

Value ($000) $163,916 Shares 2,080,946 Est. Cost $65.60 Unrealized +3.8%

GERN GERON CORP 12.4%

Value ($000) $106,185 Shares 23,915,480 Est. Cost $3.90 Unrealized 0.0%

KROS KEROS THERAPEUTICS INC 8.0%

Value ($000) $68,772 Shares 1,525,902 Est. Cost $39.55 Unrealized +35.9%

CRBP CORBUS PHARMACEUTICALS HLDGS 1.7%

Value ($000) $14,267 Shares 325,140 Est. Cost $42.06 Unrealized 0.0%

SYRE SPYRE THERAPEUTICS INC 1.2%

Value ($000) $10,266 Shares 452,040 Est. Cost $28.97 Unrealized +16.4%

RNAM AVIDITY BIOSCIENCES INC 0.9%

Value ($000) $8,108 Shares 200,000 Est. Cost $28.69 Unrealized 0.0%

— ELEVATION ONCOLOGY INC 0.6%

Value ($000) $4,810 Shares 1,916,290 Est. Cost $5.13 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CYTK	CYTOKINETICS INC	4,575,558	$246,074	28.6%	$60.36	0.0%	COM NEW	23282W605
INSM	INSMED INC	3,541,095	$237,076	27.6%	$38.78	0.0%	COM PAR $.01	457669307
PCVX	VAXCYTE INC	2,080,946	$163,916	19.1%	$65.60	+3.8%	COM	92243G108
GERN	GERON CORP	23,915,480	$106,185	12.4%	$3.90	0.0%	COM	374163103
KROS	KEROS THERAPEUTICS INC	1,525,902	$68,772	8.0%	$39.55	+35.9%	COM	492327101
CRBP	CORBUS PHARMACEUTICALS HLDGS	325,140	$14,267	1.7%	$42.06	0.0%	COM NEW	21833P301
SYRE	SPYRE THERAPEUTICS INC	452,040	$10,266	1.2%	$28.97	+16.4%	COM NEW	00773J202
RNAM	AVIDITY BIOSCIENCES INC	200,000	$8,108	0.9%	$28.69	0.0%	COM	05370A108
—	ELEVATION ONCOLOGY INC	1,916,290	$4,810	0.6%	$5.13	—	COM	28623U101